IDX targets a second-half margin recovery after a softer FY27 start

• Q1 revenue growth of 3.0%, or 4.4% excluding closed sites and constant-currency effects
• Australian revenue growth of 5.1% excluding closed sites, below estimated Medicare benefits growth of 7.1%
• FY27 revenue growth guidance set at 4% to 6%
• Full-year operating EBITDA margin guidance of 19.5% to 20.5%